Bottomline: The VA Community Care program, while crucial for expanding veteran healthcare access, can result in reimbursement...

Bottom Line: The Department of Defense (DoD) is frequently the first federal payer to formally assess newly FDA-approved pharmaceutical...

This side-by-side chart highlights the key distinctions between the VA healthcare system and Medicare, including eligibility, coverage...

Our team recently published Part II in a 3-part series aimed at helping drug manufactures gain an updated view of VA and DOD drug...

Bottom Line: The VA's updated presumptive conditions list expanding coverage for Gulf War and Post-9/11 veterans necessitates...

Bottom Line: Serving 2.8 million veterans at a $23.9 billion cost in FY2023, the VA Community Care Program expands healthcare access by...

Bottom Line: The VA's short-term community pharmacy Rx access isn't as open-ended as many assume. The Urgent/Emergent formulary contains...

Bottom Line: The VA formulary balances quality of care with cost-effectiveness by considering clinical evidence, veteran needs, and budget constraints to ensure best and appropriate access to affordable medications for the veteran population. The Department of Veterans Affairs (VA) formulary is a detailed list of medications approved for use in the VA healthcare system to optimize pharmaceutical care for veterans by promoting safety, effectiveness, and cost-efficiency. Formul

Bottom Line: The Veterans Community Care Program, a program that allows veterans to receive healthcare from community providers, utilizes...

Bottom Line: Manufacturers of biosimilars should explore and emphasize the opportunity to enhance the affordability and accessibility of...

Bottom Line: The Defense Logistic Agency (DLA) Electronic Catalog (ECAT) is an online platform that streamlines the procurement of...

Bottom Line: While an FSS contract ensures a product's availability to Federal agencies, formulary status is determined independently by...